About Shensongyangxin capsule Efficacy of sinus bradycardia.docVIP

About Shensongyangxin capsule Efficacy of sinus bradycardia.doc

  1. 1、本文档共6页,可阅读全部内容。
  2. 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
  3. 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  4. 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  5. 5、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  6. 6、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  7. 7、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  8. 8、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
About Shensongyangxin capsule Efficacy of sinus bradycardia

 PAGE \* MERGEFORMAT 6 About Shensongyangxin capsule Efficacy of sinus bradycardia Keywords:] Shensongyangxin capsule sinus bradycardia Currently, no single clinical faster heart rate, long-term use is safe and effective drugs. I used Shensongyangxin capsule were satisfied with the efficacy of sinus bradycardia, are summarized as follows reported. 1 Materials and Methods 1.1 Diagnostic criteria Reference lt;lt;Chinese medical SCIENCES “gt; [1] and” The lt;utility within SCIENCES “gt; [2] diagnostic criteria for sinus bradycardia: ① heart rategt; = 45 times / min, the minimum heart rategt; = 35 times / min, sinus arrest, long interval ≤ 2.5 s, ② no history of syncope and amaurosis, ③ the age of 18 to 70 years old. TCM is Qi deficiency with blood stasis syndrome. 1.2 General Information Observed cardiovascular specialist out-patient cases from the hospital and ward. 24 cases in treatment group, male 10 cases, 14 females, aged 44 to 70 years (mean 57.7 + -9.8) years, duration of 0.03 to 11 years (mean 3.9 + -3.2) years, by palpitations, shortness of breath, fatigue, chest tightness, insomnia, night sweats, Shen Juan made the Chinese lazy symptom score: mild in 2 cases, 18 cases of moderate and severe in 4 cases. Control group, 24 patients, 8 males and 16 females, aged 44 to 69 years, mean (60.2 ± 6.8) years, duration of 1 to 10 years, the average (3.4 + -2.2) years, Chinese medicine symptom score: 7 cases of mild , 12 cases of moderate and severe in 5 cases. The statistical analysis, general information 2 groups no statistically significant difference (Pgt; 0.05). 1.3 Treatment Treatment group: I Shensongyangxin capsule (Shijiazhuang Yiling Pharmaceutical production, batch number orally, 3 tablets / time, 3 times a day, control group: oral Xinbao (Guangdong Shantou in pharmaceutical production, batch number 2003ZL01953) , 3 capsules / time, 3 times a day. a course of 4 weeks. 1.4 Clinical Standards 1.4.1 standards of

您可能关注的文档

文档评论(0)

jiupshaieuk12 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

版权声明书
用户编号:6212135231000003

1亿VIP精品文档

相关文档